Transforming growth factor-β-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-X(L) downregulation

Experimental Cell Research

Volumn 242, Issue 1, 1998, Pages 244-254

  Saltzman, Alan ^a   Munro, Robin ^a   Searfoss, George ^a   Franks, Carol ^a   Jaye, Michael ^a   Ivashchenko, Yuri ^a  

^a SANOFI   (France)

Author keywords

Apoptosis; Bcl X(L); Bik; Caspases; Transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; DOWN REGULATION; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; IMMUNOBLOTTING; LYMPHOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 0031843551     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4096     Document Type: Article

References (48)

1. Jacobson, M. D., Weil, M., and Raff, M. C. (1997). Programmed cell death in animal development. Cell 88, 347-354.
2. Rudin, C. M., and Thompson, C. B. (1997). Apoptosis and disease: Regulation and clinical relevance of programmed cell death. Annu. Rev. Med. 48, 267-281.
3. Nagata, S. (1997). Apoptosis by death factor. Cell 88, 355-365.
4. Kroemer, G., Petit, P., Zamzami, N., Vayssière, J.-L., and Mignotte, B. (1995). The biochemistry of programmed cell death. FASEB J. 9, 1277-1287.
5. Sánchez, A., Álvarez, A. M., Benito, M., and Fabregat, I. (1996). Apoptosis induced by transforming growth factor-beta in fetal hepatocyte primary cultures: involvement of reactive oxygen intermediates. J. Biol. Chem. 271, 7416-7422.
6. Moulton, B. C. (1994). Transforming growth factor-β stimulates endometrial stromal apoptosis in vitro. Endocrinology 134, 1055-1060.
7. Warner, G .L., Ludlow, J. W., Nelson, D. A., Gaur, A., and Scott, D. W. (1992). Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor β but pRB hypophosphorylation is transforming growth factor β independent. Cell Growth Differ. 3, 175-181.
8. Attisano, L., Wrana, J. L., López-Casillas, F., and Massagué, J. (1994). TGF-β receptors and actions. Biochim. Biophys. Acta 1222, 71-80.
9. Roberts, A. B., and Sporn, M. B. (1990). The transforming growth factor-βs. In "Peptide Growth Factors and Their Receptors" (M. B. Sporn and A. B. Roberts, Ed.), Springer-Verlag, Heidelberg, Germany.
10. Derynck, R. (1994). TGF-β-receptor mediated signaling. Trends Biochem. Sci. 19, 548-553.
11. Derynck, R., and Zhang, Y. (1996). Intracellular signalling: The mad way to do it. Curr. Biol. 6, 1226-1229.
12. Kim, J., Johnson, K., Chen, H. J., Carroll, S., and Laughon, A. (1997). Drosophila Mad binds to DNA and directly mediates activation of vestigial by decapentaplegic. Nature 388, 304-308.
13. Chen, X., Rubock, M. J., and Whitman, M. (1996). A transcriptional partner for MAD proteins in TGF-β signalling. Nature 383, 691-696.
14. Korsmeyer, S. J. (1995). Regulators of cell death. Trends Genet. 11, 101-105.
15. Reed, J. C. (1997). Double identity for proteins of the Bcl-2 family. Nature 387, 773-776.
16. Chinnaiyan, A. M., O'Rourke, K., Lane, B. R., and Dixit, V. M. (1997). Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death. Science 275, 1122-1126.
17. Wu, D., Wallen, H. D., and Nuñez, G. (1997). Interaction and regulation of subcellular localization of CED-4 by CED-9. Science 275, 1126-1129.
18. Birnbaum, M. J., Clem, R. J., and Miller, L. K. (1994). An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs. J. Virol. 68, 2521-2528.
19. Crook, N. E., Clem, R. J., and Miller, L. K. (1993). An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J. Virol. 67, 2168-2174.
20. Uren, A. G., Pakusch, M., Hawkins, C. J., Puls, K. L., and Vaux, D. L. (1996). Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/ or bind tumor necrosis factor receptor-associated factors. Proc. Natl. Acad. Sci. USA 93, 4974-4978.
21. Liston, P., Roy, N., Tamai, K., Lefebvre, C., Baird, S., Cherton-Horvat, G., Farahani, R., McLean, M., Ikeda, J.-E., MacKenzie, A., and Korneluk, R. G. (1996). Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379, 349-353.
22. Deveraux, Q. L., Takahashi, R., Salvesen, G. S., and Reed, J. C. (1997). X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388, 300-304.
23. Beg, A. A., and Baltimore, D. (1996). An essential role for NF-κB in preventing TNF-α induced cell death. Science 274, 782-784.
24. Wang, C.-Y., Mayo, M. W., and Baldwin, A. S., Jr. (1996). TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274, 784-787.
25. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. (1996). Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787-789.
26. Klein, G., Giovanella, B., Westman, A., Stehlin, J. S., and Mumford, D. (1975). An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics: EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5, 319-334.
27. Chaouchi, N., Arvanitakis, L., Auffredou, M. T., Blanchard, D. A., Vazquez, A., and Sharma, S. (1995). Characterization of transforming growth factor-β1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene 11, 1615-1622.
28. Meyaard, L., Otto, S. A., Jonker, R. R., Mijnster, M. J., Keet, R. P. M., and Miedema, F. (1992). Programmed death of T cells in HIV-1 infection. Science 257, 217-219.
29. Braylan, R. C., Benson, N. A., Nourse, V., and Kruth, H. S. (1982). Correlated analysis of cellular DNA, membrane antigens, and light scatter of human lymphoid cells. Cytometry 2, 337-343.
30. Haskill, S., Beg, A. A., Tompkins, S. M., Morris, J. S., Yurochko, A. D., Sampson-Johannes, A., Mondal, K., Ralph, P., and Baldwin, A. S., Jr. (1991). Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65, 1281-1289.
31. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). Detection and analysis of proteins expressed from cloned genes. In "Molecular Cloning: A Laboratory Manual" (N. Ford, Ed.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
32. INK4B is a potential effector of TGF-β induced cell cycle arrest. Nature 371, 257-260.
33. Ignotz, R. A., and Massagué, J. (1986). Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261, 4337-4345.
34. Laiho, M., Saksela, O., Andreasen, P. A., and Keski-Oja, J. (1986). Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J. Cell Biol. 103, 2403-2410.
35. Kerr, L. D., Olashaw, N. E., and Matrisian, L. M. (1988). Transforming growth factor beta 1 and cAMP inhibit transcription of epidermal growth factor-and oncogene-induced transin RNA. J. Biol. Chem. 263, 16999-17005.
36. Arsura, M., Wu, M., and Sonnenshein, G. E. (1996). TGFβ1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: Transcriptional activation of IκB. Immunity 5, 31-40.
37. Mizushima, N., Koike, R., Kohsaka, H., Kushi, Y, Handa, S., Yagita, H., and Miyasaka, N. (1996). Ceramide induces apoptosis via CPP32 activation. FEBS Lett. 395, 267-271.
38. Robertson, N. M., Zangrilli, J., Fernandes-Alnemri, T., Friesen, P. D., Litwack, G., and Alnemri, E. S. (1997). Baculovirus P35 inhibits the glucocorticoid-mediated pathway of cell death. Cancer Res. 57, 43-47.
39. Datta, R., Kojima, H., Banach, D., Bump, N. J., Talanian, R. V., Alnemri, E. S., Weichselbaum, R. R., Wong, W. W., and Kufe, D. W. (1997). Activation of a CrmA-insensitive, p35-sensitive pathway in ionizing radiation-induced apoptosis. J. Biol. Chem. 272, 1965-1969.
40. Chen, R.-H., and Chang, T.-Y. (1997). Involvement of caspase family proteases in transforming growth factor-β-induced apoptosis. Cell Growth Differ. 8, 821-827.
41. Lavin, M. F., Watters, D., and Song, Q. (1996). Role of protein kinase activity in apoptosis. Experientia 52, 979-994.
42. 2-terminal kinase-mediated activation of interleukin-1β converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. J. Biol. Chem. 272, 4631-4636.
43. Ichijo, H., Nishida, E., Irie, K., ten Dijke, P., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., and Gotoh, Y. (1997). Induction of apoptosis by ASK1, a mammalian MAP-KKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90-94.
44. Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J., and Evan, G. (1997). Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385, 544-548.
45. Ito, T., Deng, X., Carr, B., and May, W. S. (1997). Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem. 272, 11671-11673.
46. Boyd, J M., Gallo, G. J., Elangovan, B., Houghton, A. B., Malstrom, S., Avery, B. J., Ebb, R. G., Subramanian, T., Chittenden, T., Lutz, R. J., and Chinnadurai, G. (1995). Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11, 1921-1928.
47. L rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. J. Immunol. 155, 66-75.
48. Gottschalk, A. R., Boise, L. H., Thompson, C. B., and Quintans, J. (1994). Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc. Natl. Acad. Sci. USA 91, 7350-7354.